Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- Northwestern University
- Study ID
- NCT06698146
- Status
- Recruiting
Conditions
- Colon Cancer Liver Metastases
- Colorectal Cancer Metastatic
- Liver Transplant Surgery
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Liver transplantation (LT) has become an accepted treatment for selected patients with unresectable liver metastases due to colorectal cancer (CRLM). The goal of this study is to look at and compare the clinical results of all the different approved methods (living vs. Deceased, whole organ vs. Split, one staged vs. Two staged) used to perform a standard liver transplant procedure for recipients with CRLM. Investigators will look at things like different procedure results, recovery in the hospital, and survival rates one year after the transplant. Investigators will also take blood samples from participants to be used in future research. All the transplant methods the investigators are comparing are standard practices approved by the United Network of Organ Sharing (UNOS).
Key Dates
- Start date
- Aug 27, 2025
- Status verified
- Apr 2025
- Primary completion
- Jan 1, 2034
- Completion
- Jan 1, 2035
Study Design
- Enrollment
- 80 participants (estimated)
Arms
- Arm: Living Donor Liver TransplantLiving Donor Liver Transplant using right or left lobe donor graft
- Arm: RAPID Living Donor Liver Transplant (using LLS or left lobe)Resection And Partial Liver Transplantation with Delayed Total Hepatectomy is a two staged procedure that utilized partial donor grafts and stages hepatectomies. In the first stage, a left hepatectomy is performed and a LT is performed using a donor left lateral segment split (LLS) (or left lobe split in some circumstances). Once the LT has achieved sufficient volume (typically within two weeks), a right hepatectomy is performed to remove all native liver, leaving the LT intact.
- Arm: RAPID Deceased Donor Liver Transplant (LLS or left lobe)Resection And Partial Liver Transplantation with Delayed Total Hepatectomy is a two staged procedure that utilized partial donor grafts and stages hepatectomies. In the first stage, a left hepatectomy is performed and a LT is performed using a donor left lateral segment split (LLS) (or left lobe split in some circumstances). Once the LT has achieved sufficient volume (typically within two weeks), a right hepatectomy is performed to remove all native liver, leaving the LT intact.
- Arm: Liver Transplant Deceased Donor (Whole Liver)The whole of the deceased donor liver is used. Livers from deceased donors are allocated to potential recipients according to the MELD (Model for End-Stage Liver Disease) scoring system.
Primary Outcome Measure
Graft and Patient Survival Outcomes [ Time Frame: From liver transplant to 12 months ]
Central Contacts
- Yajaira Navarro312-694-2092
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Northwestern University-Comprehensive Transplant Center | Chicago | Illinois | 60611 | Zachary Dietch, MD, MBA (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Chicago, IL
Related Studies
- Living Donor Liver Transplant for Unresectable Colorectal Liver MetastasesRecruiting · University of Rochester · Rochester, New York
- Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver MetastasesPHASE2 · Recruiting · Weill Medical College of Cornell University · New York, New York
- Medical Cannabis in Patients With Advanced Pancreatic and Colorectal CancerPHASE2 · Recruiting · HealthPartners Institute · Saint Louis Park, Minnesota
- Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)PHASE2 · Recruiting · Buzzard Pharmaceuticals · Los Angeles, California